BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32561640)

  • 1. The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration.
    Ojala VK; Knittle AM; Kirjalainen P; Merilahti JAM; Kortesoja M; Tvorogov D; Vaparanta K; Lin S; Kast J; Pulliainen AT; Kurppa KJ; Elenius K
    J Biol Chem; 2020 Aug; 295(33):11559-11571. PubMed ID: 32561640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation.
    Zeng L; Sachdev P; Yan L; Chan JL; Trenkle T; McClelland M; Welsh J; Wang LH
    Mol Cell Biol; 2000 Dec; 20(24):9212-24. PubMed ID: 11094073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vav family proteins couple to diverse cell surface receptors.
    Moores SL; Selfors LM; Fredericks J; Breit T; Fujikawa K; Alt FW; Brugge JS; Swat W
    Mol Cell Biol; 2000 Sep; 20(17):6364-73. PubMed ID: 10938113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis.
    Hunter SG; Zhuang G; Brantley-Sieders D; Swat W; Cowan CW; Chen J
    Mol Cell Biol; 2006 Jul; 26(13):4830-42. PubMed ID: 16782872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rho protein exchange factor Vav3 regulates vascular smooth muscle cell proliferation and migration.
    Toumaniantz G; Ferland-McCollough D; Cario-Toumaniantz C; Pacaud P; Loirand G
    Cardiovasc Res; 2010 Apr; 86(1):131-40. PubMed ID: 19969623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the guanine nucleotide exchange factor Vav3 in central nervous system development and plasticity.
    Ulc A; Gottschling C; Schäfer I; Wegrzyn D; van Leeuwen S; Luft V; Reinhard J; Faissner A
    Biol Chem; 2017 May; 398(5-6):663-675. PubMed ID: 28214347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity.
    Lyons LS; Burnstein KL
    Mol Endocrinol; 2006 May; 20(5):1061-72. PubMed ID: 16384856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major transcript variants of VAV3, a new member of the VAV family of guanine nucleotide exchange factors.
    Trenkle T; McClelland M; Adlkofer K; Welsh J
    Gene; 2000 Mar; 245(1):139-49. PubMed ID: 10713454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-terminal 20-amino acid region of guanine nucleotide exchange factor Vav1 plays a distinguished role in T cell receptor-mediated calcium signaling.
    Li SY; Du MJ; Wan YJ; Lan B; Liu YH; Yang Y; Zhang CZ; Cao Y
    J Biol Chem; 2013 Feb; 288(6):3777-85. PubMed ID: 23271736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct role of phosphatidylinositol 3-kinase and Rho family GTPases in Vav3-induced cell transformation, cell motility, and morphological changes.
    Sachdev P; Zeng L; Wang LH
    J Biol Chem; 2002 May; 277(20):17638-48. PubMed ID: 11884391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VAV3 in human cancers: Mechanism and clinical implication.
    Al-Hawary SIS; Alsalamy A; Gupta R; Alsaab HO; Hjazi A; Edilboyev U; Ramadan MF; Hussien BM; Ahmed M; Hosseini-Fard SR
    Pathol Res Pract; 2023 Aug; 248():154681. PubMed ID: 37467637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer.
    Lee K; Liu Y; Mo JQ; Zhang J; Dong Z; Lu S
    BMC Cancer; 2008 Jun; 8():158. PubMed ID: 18518979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vav1 and vav3 have critical but redundant roles in mediating platelet activation by collagen.
    Pearce AC; Senis YA; Billadeau DD; Turner M; Watson SP; Vigorito E
    J Biol Chem; 2004 Dec; 279(52):53955-62. PubMed ID: 15456756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas.
    Colomba A; Courilleau D; Ramel D; Billadeau DD; Espinos E; Delsol G; Payrastre B; Gaits-Iacovoni F
    Oncogene; 2008 Apr; 27(19):2728-36. PubMed ID: 17998938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells.
    Citterio C; Menacho-Márquez M; García-Escudero R; Larive RM; Barreiro O; Sánchez-Madrid F; Paramio JM; Bustelo XR
    Sci Signal; 2012 Oct; 5(244):ra71. PubMed ID: 23033540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
    Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X
    Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel interaction between the co-chaperone Cdc37 and Rho GTPase exchange factor Vav3 promotes androgen receptor activity and prostate cancer growth.
    Wu F; Peacock SO; Rao S; Lemmon SK; Burnstein KL
    J Biol Chem; 2013 Feb; 288(8):5463-74. PubMed ID: 23281476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylated cortactin recruits Vav2 guanine nucleotide exchange factor to activate Rac3 and promote invadopodial function in invasive breast cancer cells.
    Rosenberg BJ; Gil-Henn H; Mader CC; Halo T; Yin T; Condeelis J; Machida K; Wu YI; Koleske AJ
    Mol Biol Cell; 2017 May; 28(10):1347-1360. PubMed ID: 28356423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the Nucleotide Exchange Factor Vav3 Enhances Axonal Complexity and Synapse Formation but Tampers Activity of Hippocampal Neuronal Networks In Vitro.
    Wegrzyn D; Wegrzyn C; Tedford K; Fischer KD; Faissner A
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer.
    Dong Z; Liu Y; Lu S; Wang A; Lee K; Wang LH; Revelo M; Lu S
    Mol Endocrinol; 2006 Oct; 20(10):2315-25. PubMed ID: 16762975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.